North Carolina · 86828

Assessment Of Antibodies To Class I And Class Ii Human Leukocyte Antigens (hla) Antigens in North Carolina

North Carolina Medicare Avg
$62.91
1% above national avg
National Medicare Avg
$62.41
All states combined
Billed Charge (NC)
$313.37
What providers submit
Est. Commercial (NC)
$137.14
National avg: $139.79
Est. Cash / Self-Pay (NC)
$133.36
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

46
Services in NC
2
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in North Carolina

Provider Medicare Services
Laboratory Corporation Of America... $62.91 39

North Carolina Pricing in Context

In North Carolina, CPT code 86828 (Assessment Of Antibodies To Class I And Class Ii Human Leukocyte Antigens (hla) Antigens) carries an average Medicare payment of $62.91 — 1% above the national benchmark of $62.41. 2 providers across the state submitted claims for this procedure in 2023, performing 46 total services. Individual payments in NC ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in North Carolina is $313.37, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because North Carolina sits above the national Medicare average, commercial rates in the state may also run higher than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Immunology procedures, the estimated commercial insurance price in North Carolina lands near $137.14, with self-pay cash prices typically around $133.36. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Assessment Of Antibodies To Class I And Class Ii Human Leukocyte Antigens (hla) Antigens cost in North Carolina?

The average Medicare payment for Assessment Of Antibodies To Class I And Class Ii Human Leukocyte Antigens (hla) Antigens in North Carolina is $62.91, which is 1% above the national average of $62.41. Providers in NC typically bill $313.37 for this procedure.

What does Assessment Of Antibodies To Class I And Class Ii Human Leukocyte Antigens (hla) Antigens cost with insurance in North Carolina?

With commercial insurance in North Carolina, Assessment Of Antibodies To Class I And Class Ii Human Leukocyte Antigens (hla) Antigens costs an estimated $137.14. Without insurance, the estimated cash price is $133.36. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Assessment Of Antibodies To Class I And Class Ii Human Leukocyte Antigens (hla) Antigens in North Carolina?

2 providers in North Carolina billed Medicare for Assessment Of Antibodies To Class I And Class Ii Human Leukocyte Antigens (hla) Antigens in 2023, performing 46 total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Assessment Of Antibodies To Class I And Class Ii Human Leukocyte Antigens (hla) Antigens cheaper in North Carolina than the national average?

No — Assessment Of Antibodies To Class I And Class Ii Human Leukocyte Antigens (hla) Antigens costs 1% above the national average in North Carolina. The state average Medicare payment is $62.91 compared to $62.41 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial